REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)

Digital solution can limit time at port and maximise cost savings Milbros UV Graph BOSTON and LONDON, Nov. 06, 2024 (GLOBE NEWSWIRE) — Milbros, a Veson Nautical solution and the industry’s most reliable and extensive database of liquid bulk products, has launched Milbros UV Graphs, a product aimed at revolutionizing

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”) of the important December 16, 2024 lead

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate Joint Stock Company Kaspi.kz (NASDAQ: KSPI) for potential violations of the federal securities laws. If you invested in Kaspi.kz, you are encouraged to obtain additional information by visiting https://rosenlegal.com/case/joint-stock-company-kaspi-kz/. Why

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024, both dates inclusive (the “Class Period”), of the important November 29, 2024 lead plaintiff deadline.